Digital and Pharma 4.0
-
ReportCPHI Milan 2026 preview: key themes and emerging trends
Explore the key themes, technologies and emerging trends shaping pharmaceutical development, manufacturing and commercialisation ahead of CPHI Milan 2026.
-
ArticleCHO perfusion model lifts yield by letting cellular waste build up
A hybrid model built into commercial software and running a self-driving bioreactor has found that unmeasured cellular waste, not the usual metabolites, throttles perfusion yields.
-
ArticleBuilding the foundation for the orchestrated lab of the future
As pharmaceutical laboratories face mounting pressure to accelerate timelines and manage growing data complexity, intelligent laboratory operations underpin the next generation of connected, autonomous lab environments.
-
ArticleThermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility
Real-time monitoring has become standard practice in temperature-controlled distribution. The differentiator now is whether organisations can convert signals into decisions early enough to prevent excursions, reduce waste and strengthen resilience. As Vijay Paliwal, Vice President, Global Advanced Solutions & Customer Experience at Cold Chain Technologies explains, that shift is driving a new operating model for cold chain management: thermal assurance.
-
ArticleAdopting an AI-driven approach to scale with confidence
Exploring how mid-size pharma can meet European regulatory expectations without rebuilding infrastructure.
-
OpinionProcess Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.